Articles published by Immuron Limited
Immuron Presentation Australian Biologics Festival 2024
February 21, 2024
Immuron achieves record Travelan® sales
February 13, 2024
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
February 08, 2024
Immuron achieves record half yearly Travelan® sales
January 16, 2024
Immuron Clinical Trials Update
December 22, 2023
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
November 28, 2023
Immuron CEO Steven Lydeamore Investor Webinar Presentation
November 13, 2023
Immuron CEO Steven Lydeamore presented at AusBioInvest
October 30, 2023
Immuron Announces Travelan® Clinical Study Cohort 2 commences
October 18, 2023
Immuron achieves record quarterly Travelan® sales
October 11, 2023
Immuron achieves record monthly Travelan® sales
September 13, 2023
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
September 11, 2023
Immuron CEO, Steven Lydeamore to present at Bioshares
July 24, 2023
Immuron FY23 Sales increase 136% on FY22 Sales
July 05, 2023
Immuron Chairman Transition
June 30, 2023
Immuron Business Update: Letter to Shareholders
June 22, 2023
Immuron Q3 FY23 Business Update Presentation
April 19, 2023
Q3 FY23 Business Update Webinar Notification
April 11, 2023
Immuron Q3 Sales reach 150% of 1H Sales
April 06, 2023
Immuron CEO, Steven Lydeamore to host an investor webinar
February 15, 2023
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.